Effects of hormone replacement therapy on insulin resistance in postmenopausal diabetic women

Open Access Macedonian Journal of Medical Sciences

Volumn 4, Issue 1, 2016, Pages 83-88

  Bitoska, Iskra ^a   Krstevska, Branka ^a   Milenkovic, Tatjana ^a   Subeska Stratrova, Slavica ^a   Petrovski, Goran ^a   Mishevska, Sasha Jovanovska ^a   Ahmeti, Irfan ^a   Todorova, Biljana ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

Diabetes mellitus; HOMA IR; Hormone replacement therapy; Insulin resistance; Menopause

Indexed keywords

ESTRADIOL; FOLLITROPIN; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; SULFONYLUREA;

ADULT; ARTICLE; BREAST TENDERNESS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; MAMMOGRAPHY; METRORRHAGIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PROSPECTIVE STUDY;

EID: 85027412825     PISSN: None     EISSN: 18579655     Source Type: Journal    
DOI: 10.3889/oamjms.2016.024     Document Type: Article

References (44)

1. Stevenson JC. The metabolic and cardiovascular consequences of HRT. Br J Clin Pract. 1995;49: 87–90. PMid:7779651
2. Sullivan JM, Vander ZR, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med. 1990;150:2557–2562. http://dx.doi.org/10.1001/archinte.1990.00390230101014 PMid:2244772
3. Newton KM, LaCroix AZ, McKnight B, Knopp RH, Siscovick DS, Heckbert SR, Weiss NS. Estrogen replacement therapy and prognosis after first myocardial infarction. Am J Epidemiol. 1997;145:269–277. http://dx.doi.org/10.1093/oxfordjournals.aje.a009100 PMid:9012600
4. O'Keefe JH Jr, Kim SC, Hall RR, Cochran VC, Lawhorn SL, McCallister BD. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol. 1997;29:1–5. http://dx.doi.org/10.1016/S0735-1097(96)00443-3
5. Cauley JA, Seeley DG, Browner WS, Ensrud K, Kuller LH, Lipschutz RC, Hulley SB. Estrogen replacement therapy and mortality among older women: the study of osteoporotic fractures. Arch Intern Med. 1997;157:2181–2187. http://dx.doi.org/10.1001/archinte.1997.00440400031004 PMid:9342994
6. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med.1991;151:75–78. http://dx.doi.org/10.1001/archinte.1991.00400010095012 PMid:1985611
7. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, Genazzani AR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab. 1997;82: 414–417. http://dx.doi.org/10.1210/jcem.82.2.3735 PMid:9024228
8. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med. 1995;123:673–675. http://dx.doi.org/10.7326/0003-4819-123-9-199511010-00005 PMid:7574222
9. Crook D, Godsland IF, Hull J, Stevenson JC. Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Br J Obstet Gynaecol. 1997;104: 298–304. http://dx.doi.org/10.1111/j.1471-0528.1997.tb11457.x PMid:9091005
10. Cefalu WT, Wang ZQ, Werbel S, Bell-Farrow A, Crouse JR III, Hinson WH, Terry JG, Anderson R. Contribution of visceral fat mass to the insulin resistance of aging. Metabolism. 1995;44:954–959. http://dx.doi.org/10.1016/0026-0495(95)90251-1
11. Hanggi W, Lippuner K, Jaeger P, Birkhauser MH, Horber FF. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Clin Endocrinol (Oxf). 1998;48(6):691–699. http://dx.doi.org/10.1046/j.1365-2265.1998.00481.x
12. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 1991;40:1323–1326. http://dx.doi.org/10.1016/0026-0495(91)90037-W
13. Samaras K, Kelly PJ, Spector TD, Chiano MN, Campbell LV. Tobacco smoking and oestrogen replacement are associated with lower total and central fat in monozygotic twins. Int J Obes Relat Metab Disord. 1998;22:149–156. http://dx.doi.org/10.1038/sj.ijo.0800558 PMid:9504323
14. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199–208. http://dx.doi.org/10.1001/jama.1995.03520270033028
15. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB. Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab. 1992;74:1396–1400. PMid:1317387
16. O'Sullivan AJ, Ho KK. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab. 1995;80:1783–1788. PMid:7775623
17. Chmouliovsky L, Habicht F, James RW, Lehmann T, Campana A, Golay A. Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas. 1999;32:147–153. http://dx.doi.org/10.1016/S0378-5122(99)00037-7
18. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia. 1997;40:843–849. http://dx.doi.org/10.1007/s001250050758 PMid:9243107
19. Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979;28:1086–1096. http://dx.doi.org/10.1016/0026-0495(79)90146-X
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. http://dx.doi.org/10.1007/BF00280883 PMid:3899825
21. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu S. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care. 2007;30:1747–1750. http://dx.doi.org/10.2337/dc07-0358 PMid:17468352 PMCid:PMC1952235
22. Abbasi F, Reaven GM. Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism. 2011;60:1673–1676. http://dx.doi.org/10.1016/j.metabol.2011.04.006 PMid:21632070
23. Gilligan DM, Quyyumi AA, Camon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545–2551. http://dx.doi.org/10.1161/01.CIR.89.6.2545 PMid:8205663
24. Fineberg SE. Glycaemic Control and Hormone Replacement Therapy. Drugs Aging. 2000;17(6):453–461. http://dx.doi.org/10.2165/00002512-200017060-00003 PMid:11200306
25. Lindheim SR, Natelovitz M, Feldman EB, Larsen S, Khan FY, Lobo RA. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women. Obstet. Gynecol. 1994;83(2):167–172. http://dx.doi.org/10.1016/0020-7292(94)90488-x
26. The Eye Disease Care—Control Study Group. Arch. Ophtholmot. 1996;114: 545. http://dx.doi.org/10.1001/archopht.1996.01100130537006
27. Sites CK, Brochu M, Tchernof A, Poehlman ET. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women. Metabolism. 2001;50(7):835–840. http://dx.doi.org/10.1053/meta.2001.24878 PMid:11436191
28. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia. 1997;40:843–849. http://dx.doi.org/10.1007/s001250050758 PMid:9243107
29. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril. 1993;60:664–667. PMid:8405521
30. Ferrara A, Barrett-Connor E, Wingard DL, Edelstein SL. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status: the Rancho Bernardo Study 1984–1987. Diabetes Care. 1995;18: 220–225. http://dx.doi.org/10.2337/diacare.18.2.220 PMid:7729301
31. Andersson B, Mattsson LA, Hahn L, Marin P, Lapidus L, Holm G, Bengtsson BA, Bjorntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulindependent diabetes mellitus. J Clin Endocrinol Meta. 1997;82:638–643. http://dx.doi.org/10.1210/jc.82.2.638
32. Brown MD, Korytkowski MT, Zmuda JM, McCole SD, Moore GE, Hagberg JM. Insulin sensitivity in postmenopausal women: independent and combined associations with hormone replacement, cardiovascular fitness, and body composition. Diabetes Care. 2000; 23:1731–1736. http://dx.doi.org/10.2337/diacare.23.12.1731 PMid:11128342
33. Samaras K, Hayward CS, Sullivan D, Kelly RP, Campbell LV. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care. 1999;22:1401–1407. http://dx.doi.org/10.2337/diacare.22.9.1401 PMid:10480500
34. Godsland IF, Gangar K, Walton C, Cust MP, Whitehead MI, Wynn V, Stevenson JC. Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism. 1993;42:846–853. http://dx.doi.org/10.1016/0026-0495(93)90058-V
35. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril. 1993;60:664–667. PMid:8405521
36. Duncan AC, Lyall H, Roberts RN, Petrie JR, Perera MJ, Monaghan S, Hart DM, Connell JM, Lumsden MA. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. J Clin Endocrinol Metab. 1999;84:2402–2407. http://dx.doi.org/10.1210/jcem.84.7.5836 PMid:10404811
37. Andersson B, Mattsson LA, Hahn L, Marin P, Lapidus L, Holm G, Bengtsson BA, Bjorntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulindependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82:638–643. http://dx.doi.org/10.1210/jc.82.2.638
38. Puah JA, Bailey CJ. Effect of ovarian hormones on glucose metabolism in mouse soleus muscle. Endocrinology. 1985;117:1336–1340. http://dx.doi.org/10.1210/endo-117-4-1336 PMid:3896756
39. Meier DA, Garner CW. Estradiol stimulation of glucose transport in rat uterus. Endocrinology. 1987;121:1366–1374. http://dx.doi.org/10.1210/endo-121-4-1366 PMid:3653031
40. Kumagai S, Holmang A, Bjorntorp P: The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand. 1993;149:91–97. http://dx.doi.org/10.1111/j.1748-1716.1993.tb09596.x PMid:8237427
41. Rincon J, Holmang A, Wahlstrom EO, Lonnroth P, Bjorntorp P, Zierath JR, Wallberg-Henriksson H. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes. 1996;45:615–621. http://dx.doi.org/10.2337/diab.45.5.615 PMid:8621012
42. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes. 1990;39:865–870. http://dx.doi.org/10.2337/diab.39.7.865 PMid:2354749
43. Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Sakashita T, Tsuda M, Ohama K. Oral estrogen replacement therapy increases forearm reactive hyperemia accompanied by increases in serum levels of nitric oxide in postmenopausal women. Gynecol Endocrinol. 2001;15:150–157. http://dx.doi.org/10.1080/gye.15.2.150.157 PMid:11379012
44. McCrohon JA, Adams MR, McCredie RJ, Robinson J, Pike A, Abbey M, Keech AC, Celermajer DS. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol. 1996;45:435–441. http://dx.doi.org/10.1046/j.1365-2265.1996.8070816.x